Wall Street Zen downgrades Merck to Hold
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
Wall Street Zen downgraded Merck & Co. (NYSE:MRK) from Buy to Hold, even as the broader analyst consensus stays at Moderate Buy. The company posted quarterly revenue of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context